Concepedia

Author

Graham Scott

Novartis (Switzerland)

Also Known As

G. Scott, G.L. SCOTT, George J. Scott, Gianna R. Scott, Graham Scott

29

Publications

760

Citations

14

H-Index

24

Concepts

All Affiliations

Novartis (Switzerland)Novartis (United Kingdom)Novartis (United States)Takeda (United Kingdom)Takeda (Japan)
GS

About

Graham Scott is an author at Novartis (Switzerland) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

317

2

Pharmacology

7

7

202

3

Diabetes

1

1

20

4

Gastroenterology

1

1

22

5

Immunology

1

1

115

Graham Scott

×

16

Publications

726

Citations

14

H-Index

YearCitations

First experience of topical SDZ ASM 981 in children with atopic dermatitis

John Harper, A. Green, Graham Scott,

British Journal of Dermatology

2001

149

Pimecrolimus Identifies a Common Genomic Anti-inflammatory Profile, is Clinically Highly Effective in Psoriasis and is Well Tolerated

Klemens Rappersberger, Michael Komar, Leo Richter,

Journal of Investigative Dermatology

2002

115

Pharmacokinetics of Lumiracoxib in Plasma and Synovial Fluid

Graham Scott, Christiane Rordorf, Christine Reynolds,

Clinical Pharmacokinetics

2004

59

Occlusive Treatment of Chronic Hand Dermatitis with Pimecrolimus Cream 1% Results in Low Systemic Exposure, Is Well Tolerated, Safe, and Effective

Diamant Thaçi, Katrin Steinmeyer, Marie‐Eve Ebelin,

Dermatology

2003

57

Low Systemic Absorption and Good Tolerability of Pimecrolimus, Administered as 1% Cream (Elidel®) in Infants with Atopic Dermatitis – A Multicenter, 3‐Week, Open‐Label Study

Doris Staab, David M. Pariser, Alice B. Gottlieb,

Pediatric Dermatology

2005

46

Gastroduodenal tolerability of lumiracoxib vs. placebo and naproxen: a pilot endoscopic study in healthy male subjects

Christiane Rordorf, Norma Kellett, Stuart Mair,

Alimentary Pharmacology & Therapeutics

2003

46

Double‐blind, randomized, placebo‐controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of <scp>TAK</scp>‐683, an investigational metastin analogue in healthy men

Graham Scott, Irfan Ahmad, Katy Howard,

British Journal of Clinical Pharmacology

2012

42

Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: an integrated study

Clare T. Atherton, J Jones, Brian McKaig,

Clinical Gastroenterology and Hepatology

2004

42

A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis

Mark Ling, Alice B. Gottlieb, David M. Pariser,

Journal of Dermatological Treatment

2005

37

Methotrexate toxicity precipitated by azapropazone

Helena M. Daly, Graham Scott, Jaclyn A. Boyle,

British Journal of Dermatology

1986

32

Page 1